Revenue: The sum of all revenue fields included for a company's operating activities.
Bioxytran, Inc. (BIXT) Revenue data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-2.07M |
|
-- |
|
-- |
|
$1.93M |
|
$-1.93M |
|
$-0.14M |
|
$-2.07M |
|
$-2.07M |
|
$-2.07M |
|
$-2.07M |
|
$-2.07M |
|
$-2.07M |
|
$-1.93M |
|
$-1.93M |
|
112.28M |
|
112.28M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.46M |
|
-- |
|
$0.15M |
|
$0.62M |
|
$5.01M |
|
-- |
|
-- |
|
$5.01M |
|
$-4.44M |
|
$-4.55M |
|
$-4.39M |
|
113.36M |
|
| Cash Flow Statement Financials | |
$-0.24M |
|
$-0.01M |
|
$0.20M |
|
$0.51M |
|
$0.46M |
|
$-0.05M |
|
$1.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.09 |
|
-- |
|
-- |
|
-- |
|
-0.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
46.62% |
|
45.50% |
|
-336.28% |
|
47.08% |
|
$-0.04 |
|
$-0.00 |
|
$-0.00 |
|